Roka Bioscience Inc. (ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D.
You can check out OrbiMed Advisors’ latest holdings and filings here.
Please follow OrbiMed Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about OrbiMed Advisors or update its stock holdings.
Follow Samuel Isaly's OrbiMed Advisors
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
OrbiMed Advisors | 0 | 1,247,721 | 0 | 1,247,721 | 1,247,721 | 22.36% |
OrbiMed Capital GP III | 0 | 1,235,951 | 0 | 1,235,951 | 1,235,951 | 22.17% |
Samuel D. Isaly | 0 | 1,247,721 | 0 | 1,247,721 | 1,247,721 | 22.36% |
Follow Samuel Isaly's OrbiMed Advisors
Page 1 of 10 – SEC Filing
ROKA BIOSCIENCE, INC. |
(Name of Issuer) |
COMMON STOCK |
(Title of Class of Securities) |
775431109 |
(CUSIP Number) |
OrbiMed Advisors LLC |
OrbiMed Capital GP III LLC |
Samuel D. Isaly |
601 Lexington Avenue, 54th Floor |
New York, NY 10022 |
Telephone: (212) 739-6400 |
(Name, Address and Telephone Number of Person |
Authorized to Receive Notices and Communications) |
September 26, 2017 |
(Date of Event Which Requires Filing of this Statement) |